Abstract:
Present disclosure provides a portable viscometer including a body and a measuring unit disposed on one side of the body. The measuring unit includes a capillary tube detachably attached to the measuring unit, and a first sensor and a second sensor, the first and second sensors being disposed adjacent to the capillary tube and vertically spaced apart from each other, and the capillary tube includes a bead therein. The bead may be fixed on the inner surface of the capillary tube by a fixing compound which is soluble in a fluid to be measured.
Abstract:
An integrated bed for oriental medicine therapy according to an embodiment of the present invention is an integrated bed for oriental medicine therapy on which oriental medicine therapy for a patient is performed. The integrated bed for oriental medicine therapy comprises: a base bed body; a movable bed body which is coupled to the top of the base bed body so as to be rotatable about one side thereof so that the slope thereof with respect to the base bed body can be adjusted; and a driving part for generating a driving force for rotating the movable bed body with respect to the base bed body. The base bed body is partitioned into a plurality of spaces, and a therapy apparatus for treatment of a patient may be disposed in at least one space among the plurality of spaces.
Abstract:
A method of determining a facial expression type may include extracting feature points representing facial characteristics from a facial image of a user; grouping the extracted feature points into a plurality of regions; and determining a facial expression type for each of a plurality of groups using feature points and a facial expression type function corresponding to each of the groups.
Abstract:
A health state determining method is disclosed, which includes receiving a facial image of a user, obtaining at least one user database (DB) image corresponding to the facial image, and determining a health state of the user by comparing the facial image to the at least one user DB image.
Abstract:
The present invention relates to a screening composition for a therapeutic agent for coronavirus infection, comprising a CoV RdRp expression vector and a bicistronic reporter vector, a screening kit for a therapeutic agent for coronavirus infection, comprising the composition, and a method for screening a therapeutic agent for coronavirus infection using the composition or kit. When the screening composition for a therapeutic agent for coronavirus infection, provided by the present invention, is used, candidate materials that can have direct influences on the activity of CoV RdRp can be screened more quickly and easily, and thus, the composition can be widely used in the development of therapeutic agents for coronavirus infection.
Abstract:
The present invention relates to a composition containing Dolichos lablab Linn. extract as an active ingredient for easing hangovers, and preventing, alleviating or treating alcoholic gastrointestinal diseases, the composition having an effect in restoring gastrointestinal wall damaged by alcohol consumption, and being capable of reducing alcohol and acetaldehyde content in the blood as well as increasing aldehyde dehydrogenase activity therein. Therefore, the Dolichos lablab Linn. extract according to the present invention can be used for easing hangovers, and as healthy functional food or medicine that can prevent, alleviate or treat alcoholic gastrointestinal diseases.
Abstract:
The present invention relates to a composition for preventing, alleviating, or treating allergic skin diseases comprising, as an active ingredient, an extract of Gardenia fruit from which pigment is removed, and since the extract of Gardenia fruit from which pigment is removed is more effective for allergic skin diseases compared to an extract of Gardenia fruit from which pigment is not removed, the composition can be very advantageously used for allergic skin diseases, in particular, atopic dermatitis.
Abstract:
A method for treating a sleep disorder according to an embodiment of the present disclosure includes administering a composition comprising an extract of Hibiscus syriacus as an effective ingredient to a subject in need thereof. Because the Hibiscus syriacus extract of the present invention has an effect of improving sleep time deteriorated by stress, and an effect of reducing the content of corticosterone, which increases due to stress, and increasing the content of serotonin in blood. In addition, the composition has an effect of enhancing in a significant sense the expression of GABAR A α1 in cerebral cortex, which decreases due to stress, in a group administered with Hibiscus syriacus extract. As such, the composition comprising Hibiscus syriacus extract as an effective ingredient as an effective ingredient can be advantageously used as a functional health food composition or a pharmaceutical composition for preventing, ameliorating or treating sleeping disorders.
Abstract:
The present invention relates to a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases, containing a maple leaf extract as an active ingredient. The maple leaf extract exhibits an effect of inhibiting hyperemia in the eyeball in which hyperemia has been induced and an effect of inhibiting angiogenesis in the eyeball in which corneal damage has been induced, thus being effectively used in a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases.
Abstract:
Provided is a blood analysis device including a capillary tube, a photo sensor disposed on a sidewall of the capillary tube to detect blood flowing in the capillary tube, and an absorption sensor coupled to one end of the capillary tube to absorb the blood in the capillary tube.